Top 20 Companies in Global AI in Pharma and Biotech Market (2025–2035): Competitive Analysis & Forecast

Description

According to a research report published by Spherical Insights & Consulting, the Global AI in Pharma and Biotech Market Size is projected to grow from USD 4.53 Billion in 2024 to USD 245.10 Billion by 2035, at a CAGR of 43.74% during the forecast period 2025–2035. The Global AI in Pharma and Biotech Market is driven by increased drug development automation, precision medicine adoption, rising healthcare data availability, and the demand for faster, cost-efficient therapeutic solutions.

Introduction

The global AI in pharma and biotech market refers to the use of advanced computational technologies which include machine learning and natural language processing and generative models for biological and chemical data analysis. The market requires fundamental unprocessed materials which include extensive healthcare databases that contain clinical and genomic and real-world evidence data and require powerful computing systems and specialized algorithms and cloud-based platforms which provide fast data analysis and model training capabilities. The technologies find use in multiple fields which include target discovery and molecular design and toxicity forecasting and clinical trial enhancement and precision medicine and automated supply chain and production processes and pharmacovigilance data analysis. The main development in research involves combining generative artificial intelligence with multi-agent systems which produce research hypotheses at a faster rate while decreasing research periods. Multiple governments provide financial support for digital health and artificial intelligence research frameworks through data initiatives and regulatory sandboxes which enable innovative safety and compliance solutions. The drug discovery and development process has witnessed AI growth through recent industry partnerships and platform launches which indicate strong industry momentum toward transformation.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the AI in Pharma and Biotech Market.

 

AI in Pharma and Biotech Market Size & Statistics

• The Market Size for AI in Pharma and Biotech Was Estimated to be worth USD 4.53 Billion in 2024.
• The Market is Going to Expand at a CAGR of 43.74% between 2025 and 2035.
• The Global AI in Pharma and Biotech Market Size is anticipated to reach USD 245.10 Billion by 2035.
• North America is expected to generate the highest demand during the forecast period in the AI in Pharma and Biotech Market
• Asia Pacific is expected to grow the fastest during the forecast period in the AI in Pharma and Biotech Market.

Regional growth and demand

                                     

Asia Pacific is expected to grow the fastest during the forecast period in the AI in Pharma and Biotech market. Asia Pacific is expected to grow fastest due to by rising healthcare digitization, increasing AI adoption in drug discovery, expanding biotech investments, supportive government policies, and a growing pool of skilled data science and life sciences professionals.

 

North America is expected to generate the highest demand during the forecast period in the AI in Pharma and Biotech market. North America is expected to generate the highest demand due to advanced healthcare infrastructure, high AI adoption in pharma, substantial R&D investment, presence of key market players, and supportive regulatory frameworks promoting innovation and digital health solutions.

 

Top 10 Trends in the AI in Pharma and Biotech Market

• AI-driven drug discovery and design
• Precision medicine and personalized therapies
• Predictive analytics for clinical trials
• Generative AI for molecular modeling
• AI-enabled genomics and proteomics analysis
• Real-world data integration for decision-making
• Automation in bio manufacturing and supply chain
• AI-powered pharmacovigilance and safety monitoring
• Digital twins for disease modeling
• Cloud-based AI platforms for collaborative research

 

1. AI-driven drug discovery and design

AI accelerates the identification of potential drug candidates by analyzing vast chemical and biological datasets, predicting molecular interactions, and optimizing structures, significantly reducing research timelines and costs in early-stage drug development.

 

1. Precision medicine and personalized therapies

AI enables tailored treatments by analyzing genetic, proteomic, and clinical data, allowing healthcare providers to design therapies specific to individual patient profiles, improving efficacy, reducing side effects, and enhancing overall patient outcomes.

 

1. Predictive analytics for clinical trials

AI models assess patient eligibility, forecast trial outcomes, and optimize study design, minimizing risks and delays while enhancing recruitment efficiency, compliance, and success rates in clinical research.

 

1. Generative AI for molecular modeling

Generative AI tools create novel molecular structures with desired biological properties, speeding up drug innovation, identifying new therapeutic targets, and enabling faster synthesis of potential drug candidates.

 

1. AI-enabled genomics and proteomics analysis

Advanced AI algorithms analyze complex genomic and proteomic data to uncover disease mechanisms, identify biomarkers, and predict patient responses, supporting early diagnosis, precision treatment, and new drug target discovery.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the AI in Pharma and Biotech market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 20 Companies Leading the AI in Pharma and Biotech Market

1. IBM Corporation
2. Microsoft
3. NVIDIA 
4. Google 
5. Accenture
6. Atomwise Inc
7. Insilico Medicine
8. BenevolentAI Ltd
9. Exscientia
10. Cloud 
11. Pfizer
12. AstraZeneca
13. Roche
14. Novartis
15. Recursion 
16. IQVIA
17. Owkin
18. Numerate Inc

 

1. IBM Corporation

Headquarters: Armonk, New York, USA

IBM is a pioneer in enterprise AI offering platforms like Watson and watsonx that support AI integration across life sciences and pharma from data analytics analytics to clinical workflows. With a strong focus on hybrid cloud and AI ethics, IBM enables complex AI solutions for drug discovery and healthcare optimization

 

2. Microsoft

Headquarters: Redmond, Washington, USA

Microsoft drives AI innovation through Azure AI, Copilot and cloud solutions that accelerate data processing, clinical insights and collaborative research in pharma and biotech.

 

3. NVIDIA Corporation

Headquarters: Santa Clara, California, USA

NVIDIAs GPUs and AI platforms power high performance computing for molecular modeling, drug discovery AI workloads and genomic analysis for biotech firms.

 

4. Google / Alphabet

Headquarters: Mountain View, California, USA

Alphabets AI research via Google Health DeepMind and Vertex AI supports large scale data analysis, predictive modeling, and NLP for healthcare research and pharma R&D

 

Are you ready to discover more about the AI in Pharma and Biotech market?

The report provides an in-depth analysis of the leading companies operating in the global AI in Pharma and Biotech market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

Company Profiles

• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

 

1. Microsoft
2. NVIDIA Corporation
3. Google / Alphabet
4. Accenture
5. Atomwise Inc
6. Insilico Medicine
7. BenevolentAI Ltd
8. Exscientia
9. Others.

 

Conclusion

The Global AI in Pharma and Biotech Market will experience substantial growth because of increasing adoption of AI technologies and development of precision medicine and the rising availability of healthcare data. The top companies in the industry, which include IBM and Microsoft and NVIDIA and Google and Accenture, lead the way in developing new methods for drug discovery and clinical trials and genomics research. The industry experience major changes because of three key developments, which include generative AI and predictive analytics and real-world data integration. The market creates multiple